VESENTINI, FILIPPO
 Distribuzione geografica
Continente #
NA - Nord America 138
AS - Asia 48
EU - Europa 31
Continente sconosciuto - Info sul continente non disponibili 5
SA - Sud America 3
Totale 225
Nazione #
US - Stati Uniti d'America 121
IT - Italia 20
CN - Cina 16
SG - Singapore 12
CA - Canada 9
BD - Bangladesh 5
HK - Hong Kong 4
GB - Regno Unito 3
PR - Porto Rico 3
VN - Vietnam 3
BR - Brasile 2
IN - India 2
NL - Olanda 2
NP - Nepal 2
AT - Austria 1
AZ - Azerbaigian 1
CR - Costa Rica 1
DE - Germania 1
DK - Danimarca 1
EC - Ecuador 1
FI - Finlandia 1
FR - Francia 1
HN - Honduras 1
HU - Ungheria 1
ID - Indonesia 1
JM - Giamaica 1
JP - Giappone 1
NI - Nicaragua 1
SA - Arabia Saudita 1
VI - Stati Uniti Isole Vergini 1
Totale 220
Città #
San Jose 34
Council Bluffs 12
Santa Clara 12
Singapore 12
Ashburn 9
Buffalo 4
Los Angeles 4
Monza 4
Phoenix 4
Dallas 2
Florence 2
London 2
New York 2
San Juan 2
Acalanes Ridge 1
Aizawl 1
Amsterdam 1
Baku 1
Beijing 1
Boston 1
Brooklyn 1
Budapest 1
Calgary 1
Camden 1
Can Tho 1
Charleston 1
Chibougamau 1
Chicago 1
Christiansted 1
Cincinnati 1
Cleveland 1
Copenhagen 1
Denver 1
Dongqu 1
Gatineau 1
Glendale 1
Hanoi 1
Helsinki 1
Houston 1
Jeddah 1
Jenks 1
Kathmandu 1
Kerrville 1
Kingston 1
Las Piedras 1
Louisville 1
Madison 1
Managua 1
Maple 1
Milan 1
Naples 1
Navi Mumbai 1
Newark 1
Newport News 1
Ningbo 1
Nuremberg 1
Padua 1
Paris 1
Pittsfield 1
Portland 1
Queens 1
Ribeirão Preto 1
Rome 1
Sacramento 1
San Francisco 1
San José 1
San Pedro Sula 1
Santo Domingo de los Colorados 1
Sertanópolis 1
St. Albert 1
Summersville 1
Surprise 1
The Bronx 1
Tokyo 1
Toronto 1
Victoria 1
Vienna 1
Washington 1
Xinxiang 1
Totale 170
Nome #
Early antiproteinuric effect of voclosporin in patients with LN in a real-life setting: preliminary results from the VoRLiSS (Voclosporin in Real Life Setting Study) experience 64
Patient profiles and early response in patients with systemic lupus erythematosus initiating anifrolumab: interim analysis from the ongoing multicentre observational REVEAL study 59
Antiphospholipid antibody carriers and patients with quiescent antiphospholipid syndrome show persistent subclinical complement activation 55
Efficacy of belimumab in patients with SLE and haematological manifestations: retrospective analysis from the BeRLiSS 2.0 cohort 25
Prevalence, incidence, mortality and causes of death in a large cohort of patients with rheumatoid arthritis: an Italian population-based study 22
Totale 225
Categoria #
all - tutte 708
article - articoli 708
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.416


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2025/2026124 0 0 0 0 0 0 0 0 60 36 12 16
2026/2027101 24 28 31 18 0 0 0 0 0 0 0 0
Totale 225